Hormonal control of myosin heavy chain genes during development of skeletal muscles

Histochemical study of rabbit medial pterygoid muscle during postnatal development

The medial pterygoid muscle is a layered structure like the masseter muscle. This study aimed at investigating the regional differences in fiber type composition and fiber diameter of the medial pterygoid muscle in the rabbit from birth until 33 weeks of age. Histochemical analysis of the medial pterygoid muscle was performed during five developmental stages (4, 9, 12, 18, and 33 weeks after birth) in 30 male Japanese white rabbits. Six fiber types (I, IC, IIC, IIA, IIAB, and IIB) were identified by mATPase staining. An increase in diameter was observed in fiber types I and IC until 9 weeks of age, and in fiber types IIC, IIA, IIAB, and IIB until 33 weeks of age. No significant differences in fiber diameter were noted in the different regions of the pterygoid muscle. Moderate fast to slow fiber type shifts occurred from weeks 4-12; thereafter, a rapid slow to fast fiber type shift was observed. Significant differences in fiber type composition based on regional differences were noted at 4 weeks of age. However, there was no difference in fiber type composition between regions at 33 weeks. In conclusion, it was clear that the diameter and proportion of fast fibers had increased even after reaching sexual maturity in rabbits. In addition, the medial pterygoid muscle tissues appeared to be homogenous at 33 weeks of age with very few differences between regions.

A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progression

Background

Mesenchymal to Epithelial Transition (MET) plasticity is critical to cancer progression, and we recently showed that the OVOL transcription factors (TFs) are critical regulators of MET. Results of that work also posed the hypothesis that the OVOLs impact MET in a range of cancers. We now test this hypothesis by developing a model, OVOL Induced MET (OI-MET), and sub-model (OI-MET-TF), to characterize differential gene expression in MET common to prostate cancer (PC) and breast cancer (BC).

Results

In the OI-MET model, we identified 739 genes differentially expressed in both the PC and BC models. For this gene set, we found significant enrichment of annotation for BC, PC, cancer, and MET, as well as regulation of gene expression by AP1, STAT1, STAT3, and NFKB1. Focusing on the target genes for these four TFs plus the OVOLs, we produced the OI-MET-TF sub-model, which shows even greater enrichment for these annotations, plus significant evidence of cooperation among these five TFs. Based on known gene/drug interactions, we prioritized targets in the OI-MET-TF network for follow-on analysis, emphasizing the clinical relevance of this work. Reflecting these results back to the OI-MET model, we found that binding motifs for the TF pair AP1/MYC are more frequent than expected and that the AP1/MYC pair is significantly enriched in binding in cancer models, relative to non-cancer models, in these promoters. This effect is seen in both MET models (solid tumors) and in non-MET models (leukemia). These results are consistent with our hypothesis that the OVOLs impact cancer susceptibility by regulating MET, and extend the hypothesis to include mechanisms not specific to MET.

Conclusions

We find significant evidence of the OVOL, AP1, STAT1, STAT3, and NFKB1 TFs having important roles in MET, and more broadly in cancer. We prioritize known gene/drug targets for follow-up in the clinic, and we show that the AP1/MYC TF pair is a strong candidate for intervention.

Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase

Although thyroid hormones are critically important for the coordination of morphogenic processes in the fetus and neonate, premature exposure of the embryo to levels of the hormones present in the adult is detrimental and can result in growth retardation, malformations, and even death. We report here that the pregnant rat uterus expresses extremely high levels of the type 3 iodothyronine deiodinase (D3), which inactivates thyroxine and 3,3', 5-triiodothyronine by 5-deiodination. Both D3 mRNA and activity were present at the implantation site as early as gestational day 9 (E9), when expression was localized using in situ hybridization to uterine mesometrial and antimesometrial decidual tissue. At later stages of gestation, uterine D3 activity remained very high, and the levels exceeded those observed in the placenta and in fetal tissues. After days E12 and E13, as decidual tissues regressed, D3 expression became localized to the epithelial cells lining the recanalized uterine lumen that surrounds the fetal cavity. These findings strongly suggest that the pregnant uterus, in addition to the placenta, plays a critical role in determining the level of exposure of the fetus to maternal thyroid hormones.

The final common pathway in postural control--developmental perspective

A brief review is given concerning postural specialisations among mammalian muscle fibres and motor units. Most skeletal muscles contain a mixture of fibres with different characteristics, and their slow-twitch (S) units are well-known to possess properties suitable for postural tasks: they are highly fatigue-resistant, well equipped for oxidative metabolism, and their slowness makes them energetically cheap in (semi-)isometric contractions. These features are adequately employed in motor behaviour owing to characteristics of the associated motoneurones. In adult mammals, the way in which a muscle is used can influence its proportion of S units. This adjustment occurs within a restricted 'adaptive range' which differs between muscles and animal species, presumably being preset at an early age. In the course of early foetal development, part of the slow vs. fast differentiation of muscle fibre properties can take place independently of innervation. Once innervation has taken place, however, motoneurones influence the differentiation in various ways. On the whole, a well coordinated timing seems to exist between the early differentiation of central motor mechanisms and of the peripheral machinery, largely causing the neuromuscular system to be/become ready for use when the brain needs it.

Differential distribution of subsets of myofibrillar proteins in cardiac nonstriated and striated myofibrils

Cultured cardiac myocytes were stained with antibodies to sarcomeric alpha-actinin, troponin-I, alpha-actin, myosin heavy chain (MHC), titin, myomesin, C-protein, and vinculin. Attention was focused on the distribution of these proteins with respect to nonstriated myofibrils (NSMFs) and striated myofibrils (SMFs). In NSMFs, alpha-actinin is found as longitudinally aligned, irregular approximately 0.3-microns aggregates. Such aggregates are associated with alpha-actin, troponin-I, and titin. These I-Z-I-like complexes are also found as ectopic patches outside the domain of myofibrils in close apposition to the ventral surface of the cell. MHC is found outside of SMFs in the form of discrete fibrils. The temporal-spatial distribution and accumulation of the MHC-fibrils with respect to the I-Z-I-like complexes varies greatly along the length of the NSMFs. There are numerous instances of I-Z-I-like complexes without associated MHC-fibrils, and also cases of MHC-fibrils located many microns from I-Z-I-like complexes. The transition between the terminal approximately 1.7-microns sarcomere of any given SMF and its distal NSMF-tip is abrupt and is marked by a characteristic narrow alpha-actinin Z-band and vinculin positive adhesion plaque. A titin antibody T20, which localizes to an epitope at the Z-band in SMFs, precisely costains the 0.3-microns alpha-actinin aggregates in ectopic patches and NSMFs. Another titin antibody T1, which in SMFs localizes to an epitope at the A-I junction, typically does not stain ectopic patches and NSMFs. Where detectable, the T1-positive material is adjacent to rather than part of the 0.3-microns alpha-actinin aggregates. Myomesin and C-protein are found only in their characteristic sarcomeric locations (even in just perceptible SMFs). These A-band-associated proteins appear to be absent in ectopic patches and NSMFs.